GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDASSETS INC. (MDAS) [hlAlert]

Rating:
Buy MDAS
up 29.38 %

MEDASSETS INC. (MDAS) rated Buy with price target $20 by Auriga U.S.A

Posted on: Thursday,  Jun 11, 2009  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy MEDASSETS INC. (NASDAQ: MDAS) on 06/11/2009, when the stock price was $18.00. Since then, MEDASSETS INC.
has gained 29.39% of its value until Auriga U.S.A rated MDAS Hold on 10/27/2009, when the price was $23.29.
If you would have followed this Auriga U.S.A's recommendation on MDAS, you would have gained 29.38% of your investment in 138 days.

MedAssets, Inc. provides technology-enabled products and services, which together deliver solutions designed to improve operating margin and cash flow for hospitals and health systems. These solutions are offered primarily through Company-hosted software, or software as a service (SaaS), supported by enterprise-wide sales, account management, implementation services and consulting. The Company delivers its solutions through two business segments: Revenue Cycle Management, which provides a suite of products and services that span what has traditionally been viewed as the hospital revenue cycle, and Spend Management, which helps customers manage their non-labor expense categories through a combination of group purchasing, performance improvement consulting, including implantable physician preference items (PPI), cost and utilization management and service line consulting, and business intelligence tools. On June 2, 2008, the Company acquired Accuro Healthcare Solutions, Inc.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2011 8:25 AM Buy
None
15.10 22.00
as of 12/31/2009
1 Week   
1 Month   
3 Months up  3.19 %
1 YTD up  29.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/16/2010 8:25 AM Buy
None
20.47 26.00
11/19/2009 8:25 AM Hold
None
23.46 23.00
10/27/2009 8:25 AM Hold
None
23.29 25.00
6/11/2009 8:25 AM Buy
None
18.00 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy